Healthcare reform in the United States and China: pharmaceutical market implications - Wikidata - wikimedia - TriplyDB

Healthcare reform in the United States and China: pharmaceutical market implications

Healthcare reform in the United States and China: pharmaceutical market implications

http://www.wikidata.org/entity/Q33984685

about

Prescribing efficiency of proton pump inhibitors in China: influence and future directions Generic drugs: Review and experiences from South India.Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens Improving viable low cost generic medication prescription rate in primary care pediatric practice.Demonstrating the value of medicines: evolution of value equation and stakeholder perception of uncertainties.Drug utilization and medication costs at the end of life.ePrescribing: Reducing Costs through In-Class Therapeutic Interchange.

P2860

Q35021173-404BD3FB-7188-4D5F-B132-9091BA4D8F02 Q35948976-C5EC00F6-F430-4A24-A731-A889E582A314 Q36206941-CA83F409-2E3D-478C-8357-3344E8081318 Q36409306-ADF7C0BB-F4B6-4089-8E3D-B28A84EB0C4B Q37116554-083FE292-48AF-4D79-96F0-3B086EB0520D Q38751597-1A2CFED6-C81D-4BA4-8E69-0E3EF30DF884 Q39103163-1593CD82-7A40-4288-9FF4-AED515DDC412

P2860

Healthcare reform in the United States and China: pharmaceutical market implications

http://www.wikidata.org/entity/Q33984685

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Healthcare reform in the United States and China: pharmaceutical market implications

@ast

Healthcare reform in the United States and China: pharmaceutical market implications

@en

type

label

Healthcare reform in the United States and China: pharmaceutical market implications

@ast

Healthcare reform in the United States and China: pharmaceutical market implications

@en

prefLabel

Healthcare reform in the United States and China: pharmaceutical market implications

@ast

Healthcare reform in the United States and China: pharmaceutical market implications

@en

P1433

Q33984685-CFAB22E2-0FFD-45B2-AF69-F05319077352

P1476

Q33984685-C52ACE88-2623-4343-B4C0-717B59AB9ED2

P2093

Q33984685-49102502-4BFB-4C48-84ED-E3FC9EEA7DB7

P2860

Q33984685-1E84A510-D1BE-4949-AB65-418DAE2A0E67

Q33984685-432EDBD5-1CDF-456A-B7F2-9345DF0E25C3

Q33984685-44325B02-E01E-4DE2-8201-E58CC62F7C88

Q33984685-4B4EA94D-11A9-47D3-AE49-C56A8E01D07C

Q33984685-4FC0097F-378B-4980-BDF0-67CEA828A28B

Q33984685-56699474-D531-4DF8-B0B4-03A8B2AF32F9

Q33984685-7A54350A-C0CC-4FDA-850C-89C5C6DB5CAB

Q33984685-7E745075-D535-4953-82E9-C1AC4B7762DE

Q33984685-85E3C180-507B-4F64-B7C3-1E39D0B775BB

Q33984685-97722CDF-C849-43E9-B596-FB1FDF0545AD

P2888

Q33984685-3F34319C-F363-4DEB-BBC6-0E5D29D2BDAA

P304

Q33984685-07A96119-D06A-48D7-89E2-C83150C7E130

P31

Q33984685-BA6F9099-C1C7-412C-8723-8834C149117D

P356

Q33984685-1158716B-4C3D-450D-BE9B-E4DBD35696AF

P433

Q33984685-07A65BB5-5BE7-41A5-A2E5-629AD50B813D

P478

Q33984685-340D2170-384F-4424-B04A-D22E3D6EF46F

P50

Q33984685-91362AB2-DC41-45BC-8B5C-099038E67138

P577

Q33984685-70403475-B633-4C7D-9176-42178E64512C

P5875

Q33984685-74D34A9C-F18F-46D1-A04B-44139A60367E

P6179

Q33984685-BFBCB9D4-BC3C-4372-BCAE-5DDBA7B8F6B6

P698

Q33984685-F10B4EBF-C3E7-4F3F-BBD0-A8FEE4524E49

P921

Q33984685-F7369C56-3891-44A7-908E-1F27C3B3BDE4

P932

Q33984685-71530981-8D3B-4658-A049-D4A12153C9EF

P356

P1433

Journal of pharmaceutical policy and practice

P1476

Healthcare reform in the United States and China: pharmaceutical market implications

@en

P2093

Ansuman Mohanty

http://www.w3.org/2001/XMLSchema#string

P2860

Realignment of incentives for health-care providers in China

National health spending projections through 2020: economic recovery and reform drive faster spending growth.

The political economy of healthcare reform in China: negotiating public and private.

A political history of medicare and prescription drug coverage.

National medicines policies - a review of the evolution and development processes.

Early appraisal of China's huge and complex health-care reforms.

The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries.

National health expenditure projections: modest annual growth until coverage expands and economic growth accelerates.

The Urban Resident Basic Medical Insurance: a landmark reform towards universal coverage in China.

Development and status of health insurance systems in China.

P2888

P304

9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2052-3211-7-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Arthur A Daemmrich

P577

2014-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264539552

http://www.w3.org/2001/XMLSchema#string

P6179

1044899386

http://www.w3.org/2001/XMLSchema#string

P698

25097759

http://www.w3.org/2001/XMLSchema#string

P921

P932

4117976

http://www.w3.org/2001/XMLSchema#string